Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms

Details for Australian Patent Application No. 2003239357 (hide)

Owner Philadelphia Health and Education Corporation(D/B/A MCP Hahnemann University)

Inventors Stearns, Mark; Wang, Min; Hu, Youji

Agent Pizzeys

Pub. Number AU-B-2003239357

PCT Number PCT/US03/14098

PCT Pub. Number WO2003/094844

Priority 10/140,602 07.05.02 US

Filing date 7 May 2003

Wipo publication date 24 November 2003

Acceptance publication date 20 May 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 10/140,602 07.05.02 US

15 January 2004 Application Open to Public Inspection

  Published as AU-B-2003239357

18 June 2009 Corrigenda

  Applications OPI - Name Index Under the name Philadelphia Health and Education Corporation(D/B/A MCP Hahnemann University), Application No. 2003239357, under INID (43) correct the Publication Date to read 24 November 2003

20 May 2010 Application Accepted

  Published as AU-B-2003239357

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003239358-METHOD TO MAKE NANOLAMINATE THERMAL BARRIER COATINGS

2003239356-Identification of novel broadly crossreactive HIV-1 neutralizing human monoclonal antibodies